288 Results for "

ATP-binding

" in MedChemExpress (MCE) Product Catalog:
Products (288)

288 Results for "ATP-binding" in MCE Product Catalog:

Cat. No.: HY-184305
Target:  

c-Met/HGFR

Domaines de recherche:  

Cancer

c-Met-IN-30 is a c-MET inhibitor. c-Met-IN-30 inhibits the proliferation of non-small cell lung cancer, pancreatic ductal adenocarcinoma and triple-negative breast adenocarcinoma, and can be used in the research of the above-mentioned cancers .
loading...
    loading...
Cat. No.: HY-189261
Domaines de recherche:  

Cancer

Anticancer agent-361 is a glycine-conjugated coumarin-quinazoline fused heterocyclic derivative with selective antitumor proliferation activity. Anticancer agent-361 induces G0/G1 cell cycle arrest, apoptosis, and LDH release accompanied by membrane damage. Anticancer agent-361 is predicted to be a PI3Kα/PI3Kγ inhibitor. Anticancer agent-361 can be used for research on lung cancer, pancreatic cancer, prostate cancer, and breast cancer .
loading...
    loading...
Cat. No.: HY-40351
CAS No.: 3680-69-1
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine is a nitrogen-containing heterocyclic organic synthesis intermediate that can be used for the synthesis of JAK and PKB/Akt inhibitors .
loading...
    loading...
Cat. No.: HY-189471
Domaines de recherche:  

Cancer

VEGFR2/C-RAF kinase-IN-1 is a type II dual kinase inhibitor targeting VEGFR2 and C-RAF, with IC50 values of 12.22 nM and 38.04 nM, respectively. VEGFR2/C-RAF kinase-IN-1 binds VEGFR2 and CRAF in a Type-II mode and inhibits the downstream Raf-MEK-ERK signaling cascade. VEGFR2/C-RAF kinase-IN-1 induces cell cycle arrest, apoptosis, and intracellular ROS accumulation in H1299 cells, while partially inhibiting P-gp efflux function. VEGFR2/C-RAF kinase-IN-1 can be used for cancer research, such as non-small cell lung cancer and liver cancer .
loading...
    loading...
Cat. No.: HY-189220
Domaines de recherche:  

Inflammation/Immunology

RIPK3-IN-8 is an orally active and selective RIPK3 inhibitor with a Kd of 150 nM. RIPK3-IN-8 disrupts the formation of the RIPK3-MLKL necrosome and reduces the phosphorylation of downstream MLKL. RIPK3-IN-8 inhibits necroptosis. RIPK3-IN-8 increases the survival rate in a mouse model of TNF-α/Z-VAD-fmk (HY-16658B)-induced systemic inflammatory response syndrome. RIPK3-IN-8 is used for the research of systemic inflammatory response syndrome .
loading...
    loading...
Cat. No.: HY-171884
CAS No.: 2769714-36-3
Target:  

EGFR

Domaines de recherche:  

Cancer

BI-8128 is a potent EGFR inhibitor, with IC50 values of 12, 6.7, 22, 10, and 3 nM against wild-type, T790M, C797S, T790M/C797S, and L858R/T790M/C797S mutant EGFR, respectively. BI-8128 significantly inhibits the proliferation of Ba/F3 and PC-9 drug-resistant mutant cells. BI-8128 is applicable for the research of non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-116969
CAS No.: 17954-98-2
Pureté:  ≥98.0%
Synonyms: Narthesterol
22 (R)-Hydroxycholesterol (Narthesterol) is a natural oxysterol, acting as a LXRα agonist that inhibits cancer cell proliferation. 22 (R)-Hydroxycholesterol activates LXRα-mediated upregulation of downstream ABCA1 expression, enhances apolipoprotein-dependent cholesterol efflux, reduces intracellular cholesterol content, and decreases the production of β-amyloid peptide. 22 (R)-Hydroxycholesterol induces the differentiation of human mesenchymal stem cells into functional dopaminergic neurons. 22 (R)-Hydroxycholesterol is applicable to research related to cancer, Alzheimer's disease, and Parkinson's disease .
loading...
    loading...
Cat. No.: HY-116969S
CAS No.: 1246302-93-1
Synonyms: Narthesterol-d7
22(R)-Hydroxycholesterol-d7 (Narthesterol-d7) is the deuterated-labeled 22(R)-Hydroxycholesterol (HY-116969). 22 (R)-Hydroxycholesterol (Narthesterol) is a natural oxysterol, acting as a LXRα agonist that inhibits cancer cell proliferation. 22 (R)-Hydroxycholesterol activates LXRα-mediated upregulation of downstream ABCA1 expression, enhances apolipoprotein-dependent cholesterol efflux, reduces intracellular cholesterol content, and decreases the production of β-amyloid peptide. 22 (R)-Hydroxycholesterol induces the differentiation of human mesenchymal stem cells into functional dopaminergic neurons. 22 (R)-Hydroxycholesterol is applicable to research related to cancer, Alzheimer's disease, and Parkinson's disease .
loading...
    loading...